je.st
news
Tag: merck
Emulate Announces Expanded Collaboration With Merck To Use Organ-Chips In Drug Discovery And Development Process For Inflammatory Diseases
2016-01-06 06:17:13| drugdiscoveryonline Home Page
Emulate Inc. recently announced an expanded research collaboration with Merck, known as MSD outside the United States and Canada, to deploy Emulate’s Organ-Chips across certain Merck discovery programs to improve models of human inflammatory diseases and better predict the potential human response of therapeutic candidates
Tags: development
process
drug
expanded
CEO Frazier: Merck is eager for deals, sees strong prospects for drugs for cancer, hepatitis C
2016-01-05 22:22:53| Biotech - Topix.net
Merck's chief executive says the drugmaker is "raring to go" on deals this year, particularly for small and midsize acquisitions of companies or their experimental drugs. CEO Kenneth Frazier, speaking Tuesday at a Goldman Sachs conference of CEOs of health care companies in Boston, also said he expects more approvals and growing sales from new cancer drug Keytruda.
Tags: strong
deals
cancer
drugs
Merck to Hold Fourth-Quarter and Full-Year 2015 Sales and Earnings Conference Call on February 3
2016-01-05 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter and full-year 2015 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Wednesday, Feb. 3. During the call, company executives will provide an overview of Mercks performance for the quarter and full year. Language: English Contact: MerckMedia Contacts:Lainie Keller, 908-236-5036Steven Cragle, 908-740-1801orInvestor Contacts:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Merck to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
2016-01-04 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, Mercks chairman and chief executive officer, is scheduled to participate at the Goldman Sachs Healthcare CEOs Unscripted: A View from the Top meeting in Boston on Tuesday, Jan. 5 at 10:15 a.m. EST. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at: http://www.merck.com/investors/events-and-presentations/home.html. Language: English Contact: MerckMediaLainie Keller, 908-236-5036Steven Cragle, 908-740-1801orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Merck & Co., Inc. (MRK) Upgraded to Hold at Vetr Inc.
2016-01-03 06:31:26| Biotech - Topix.net
The firm presently has a $52.99 target price on the stock. Vetr 's target price points to a potential upside of 0.32% from the company's previous close.
Sites : [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] next »